Successful vaccines for naturally occurring protozoal diseases of animals should guide human vaccine research. A review of protozoal vaccines and their designs

Parasitology

Volumn 141, Issue 5, 2014, Pages 624-640

  McAllister, Milton M ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

animal models of human disease; apicomplexa; attenuation; efficacy; malaria; one medicine; Protozoal diseases; review; vaccination

Indexed keywords

LIVE VACCINE; MALARIA VACCINE; PROTOZOAL VACCINE;

APICOMPLEXA; DRUG DESIGN; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; HUMAN; IMMUNIZATION; IN VIVO STUDY; MALARIA; NONHUMAN; PRIORITY JOURNAL; PROTOZOAL INFECTION; REVIEW; ANIMAL; ANIMAL MODELS OF HUMAN DISEASE; ATTENUATION; DISEASE MODEL; ECONOMICS; EFFICACY; FINANCIAL MANAGEMENT; LEGAL ASPECT; ONE MEDICINE; PROTOZOAL DISEASES; STANDARD; VACCINATION; VETERINARY MEDICINE;

ANIMALIA; APICOMPLEXA;

ANIMAL MODELS OF HUMAN DISEASE; APICOMPLEXA; ATTENUATION; EFFICACY; MALARIA; ONE MEDICINE; PROTOZOAL DISEASES; REVIEW; VACCINATION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MALARIA; PROTOZOAN INFECTIONS; PROTOZOAN VACCINES; RESEARCH SUPPORT AS TOPIC; VACCINATION; VETERINARY MEDICINE;

EID: 84904736092     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182013002060     Document Type: Review

References (105)

1. Agnandji, S. T., Lell, B., Fernandes, J. F., Abossolo, B.P., Methogo, B.G., Kabwende, A. L., Adegnika, A. A., Mordmuller, B., Issifou, S., Kremsner, P. G., Sacarlal, J., Aide, P., Lanaspa, M., Aponte, J. J., Machevo, S., Acacio, S., Bulo, H., Sigauque, B., Macete, E., Alonso, P., Abdulla, S., Salim, N., Minja, R., Mpina, M., Ahmed, S., Ali, A. M., Mtoro, A. T., Hamad, A. S., Mutani, P., Tanner, M. et al. (2012). A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants. New England Journal of Medicine 367, 2284-2295. doi: 10.1056/NEJMoa1208394.
2. Akpo, Y., Kpodekon, M. T., Djago, Y., Licois, D. and Youssao, I. A. (2012). Vaccination of rabbits against coccidiosis using precocious lines of Eimeria magna and Eimeria media in Benin. Veterinary Parasitology 184, 73-76. doi: 10.1016/j.vetpar.2011.08.012.
3. Ali, A.M., Beyer, D., Bakheit, M.A., Kullmann, B., Salih, D. A., Ahmed, J. S. and Seitzer, U. (2008). Influence of subculturing on gene expression in a Theileria lestoquardi-infected cell line. Vaccine 26 (Suppl. 6), G17-G23. doi: 10.1016/j.vaccine.2008.10.009.
4. Alonso, M., Blandino, T., Mendoza, E., Savon, L. and Camacho, M. (1994). Development of a Babesia bovis live attenuated vaccine. Archivos de Medicina Veterinaria 25, 273-277.
5. Ameen, M. (2010). Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clinical and Experimental Dermatology 35, 699-705. doi: 10.1111/j.1365-2230.2010.03851.x.
6. Armijos, R. X., Weigel, M. M., Aviles, H., Maldonado, R. and Racines, J. (1998). Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during thefirst12months of follow-up. Journalof Infectious Diseases 177, 1352-1357.
7. Armijos, R. X., Weigel, M. M., Romero, L., Garcia, V. and Salazar, J. (2003). Field trial of a vaccine against new world cutaneous leishmaniasis in an at-risk child population: how long does protection last? Journal of Infectious Diseases 187, 1959-1961. doi: 10.1086/375399.
8. Baltzell, P., Newton, H. and O'Connor, A. M. (2013). A critical review and meta-analysis of the efficacy of whole-cell killed Tritrichomonas foetus vaccines in beef cattle. Journal of Veterinary Internal Medicine 27, 760-770. doi: 10.1111/jvim.12112.
9. Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, T., Gould, J., Dubois, M. C., Demoitie, M. A., Stallaert, J. F., Vansadia, P., Carter, T., Njuguna, P., Awuondo, K. O., Malabeja, A., Abdul, O., Gesase, S., Mturi, N., Drakeley, C. J., Savarese, B., Villafana, T., Ballou, W. R., Cohen, J., Riley, E. M., Lemnge, M. M., Marsh, K. and von Seidlein, L. (2008). Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age. New England Journal of Medicine 359, 2521-2532. doi: NEJMoa0807381 [pii] 10.1056/NEJMoa0807381.
10. Bock, R.E. and deVos, A. J. (2001). Immunity following use of Australian tick fever vaccine: a review of the evidence. Australian Veterinary Journal 79, 832-839.
11. Bock, R. E., Jorgensen, W. K. and Molloy, J. B. (2008). Bovine babesiosis. In Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (Mammals, Birds, and Bees), Vol. 2, pp. 611-623. Office International des Epizooties, Paris, France.
12. Borja-Cabrera, G. P., Correia Pontes, N. N., da Silva, V. O., Paraguai de Souza, E., Santos, W. R., Gomes, E. M., Luz, K. G., Palatnik, M.and Palatnik de Sousa, C. B. (2002). Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN). Vaccine 20, 3277-3284.
13. Boulter, N. and Hall, R. (1999). Immunity and vaccine developmentin the bovine theilerioses. Advances in Parasitology 44, 41-97.
14. Butcher, G. A., Mitchell, G. H. and Cohen, S. (2010). Plasmodium knowlesi infections in a small number of non-immune natural hosts (Macaca fascicularis) and in rhesus monkeys (M. mulatta). Transactions of the Royal Society of Tropical Medicine and Hygiene 104, 75-77. doi: 10.1016/j.trstmh.2009.05.017.
15. Buxton, D. (1993). Toxoplasmosis: the first commercial vaccine. Parasitology Today 9, 335-337.
16. Buxton, D. and Innes, E. A. (1995). A commercial vaccine for ovine toxoplasmosis. Parasitology 110 (Suppl.), S11-S16.
17. Buxton, D., Thomson, K.M., Maley, S., Wright, S. and Bos, H. J. (1993). Experimental challenge of sheep 18 months after vaccination with a live (S48) Toxoplasma gondii vaccine. Veterinary Record 133, 310-312.
18. Callow, L. L., Dalgliesh, R. J. and de Vos, A. J. (1997). Development of effective living vaccines against bovine babesiosis-the longest field trial? International Journal for Parasitology 27, 747-767.
19. Choromanski, L. and Block, W. (2000). Humoral immune responses and safety of experimental formulations of inactivated Neospora vaccines. Parasitology Research 86, 851-853.
20. Cobo, E. R., Morsella, C., Cano, D., Cipolla, A. and Campero, C. M. (2004). Immunization in heifers with dual vaccines containing Tritrichomonas foetus and Campylobacter fetus antigens using systemic and mucosal routes. Theriogenology 62, 1367-1382.
21. Collins, W. E. (1988). Major animal models in malaria research: simian. In Malaria Principles and Practice of Malariology, Vol. II (ed. Wernsdorfer, W. H. and McGregor, I.), pp. 1473-1501. Churchill Livingstone, Edinburgh, UK.
22. Collins, W. E. and Jeffery, G. M. (1999). A retrospective examination of secondary sporozoite-and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. American Journal of Tropical Medicine and Hygiene 61 (1 Suppl.), 20-35.
23. Cornelissen, A.W. and Schetters, T.P. (1996). Vaccines against protozoal diseases of veterinary importance. FEMS Immunology and Medical Microbiology 15, 61-72.
24. Cox, F. E.G. (1988). Major animal models in malaria research: rodent. In Malaria Principles and Practice of Malariology, Vol. 2 (ed. Wernsdorfer, W. H. and McGregor, I.), pp. 1503-1543. Churchill Livingstone, Edinburgh, UK.
25. Cummings, J. F., Spring, M.D., Schwenk, R. J., Ockenhouse, C. F., Kester, K.E., Polhemus, M. E., Walsh, D. S., Yoon, I. K., Prosperi, C., Juompan, L. Y., Lanar, D.E., Krzych, U., Hall, B. T., Ware, L. A., Stewart, V.A., Williams, J., Dowler, M., Nielsen, R. K., Hillier, C. J., Giersing, B. K., Dubovsky, F., Malkin, E., Tucker, K., Dubois, M. C., Cohen, J. D., Ballou, W. R. and Heppner, D. G., Jr. (2010). Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection. Vaccine 28, 5135-5144. doi: 10.1016/j.vaccine.2009.08.046.
26. Darko, C. A., Angov, E., Collins, W. E., Bergmann-Leitner, E. S., Girouard, A. S., Hitt, S. L., McBride, J. S., Diggs, C. L., Holder, A. A., Long, C. A., Barnwell, J.W. and Lyon, J. A. (2005). The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. Infection and Immunity 73, 287-297. doi: 10.1128/IAI.73.1.287-297.2005.
27. Di Giulio, G., Lynen, G., Morzaria, S., Oura, C. and Bishop, R. (2009). Live immunization against East Coast fever-current status. Trends in Parasitology 25, 85-92. doi: 10.1016/j.pt.2008.11.007.
28. Dunachie, S. J., Walther, M., Epstein, J. E., Keating, S., Berthoud, T., Andrews, L., Andersen, R. F., Bejon, P., Goonetilleke, N., Poulton, I., Webster, D.P., Butcher, G., Watkins, K., Sinden, R. E., Levine, G. L., Richie, T. L., Schneider, J., Kaslow, D., Gilbert, S. C., Carucci, D. J. andHill, A.V. (2006). A DNA prime-modified vaccinia virus Ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge. Infection and Immunity 74, 5933-5942. doi: 10.1128/IAI.00590-06.
29. Dunning, N. (2009). Leishmania vaccines: from leishmanization to the era of DNA technology. Bioscience Horizons 2, 73-82.
30. Echaide, I. E. (2008). Bovine babesiosis: vaccines [Babesiosis dos bovinos: vacinas]. In XV Congresso Brasileiro de Parasitologia Veterinária. Instituto Nacional de Tecnología Agropecuraria, Curitaba, Parana, Brasil.
31. EMA (2011). European Medicines Agency, Scientific discussion of CaniLeish. http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Public-assessment-report/veterinary/002232/WC500104953. pdf.
32. Fernandes, A. P., Costa, M. M., Coelho, E. A., Michalick, M. S., de Freitas, E., Melo, M. N., Luiz Tafuri, W., Resende Dde, M., Hermont, V., Abrantes Cde, F. and Gazzinelli, R.T. (2008). Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Vaccine 26, 5888-5895. doi: 10.1016/j.vaccine.2008.05.095.
33. Frenkel, J. K., Pfefferkorn, E. R., Smith, D. D. and Fishback, J. L. (1991). Prospective vaccine prepared from a new mutant of Toxoplasma gondii for use in cats. American Journal of Veterinary Research 52, 759-763.
34. Freyburger, L., Lemaitre, L., Medaille, C., Oberli, F., Fanchon, L. and Bergamo, P. (2011). [Comparative safety study of two commercialised vaccines against canine babesiosis induced by Babesia canis]. Parasite 18, 311-318.
35. Freyre, A., Choromanski, L., Fishback, J. L. and Popiel, I. (1993). Immunization of cats with tissue cysts, bradyzoites, and tachyzoites of the T-263 strain of Toxoplasma gondii. Journal of Parasitology 79, 716-719.
36. GALVmed (2010). GALVmed and East Coast Fever. November Newsletter. http://www.galvmed.org/newsletter-november-2010-galvmed-and-east-coast-fever/.
37. Garnham, P.C. C. (1966). II. Life cycle and morphology. In Malaria Parasites and Other Haemosporidia, pp. 17-59. Blackwell Scientific, Oxford, UK.
38. Garnham, P.C. C. (1980). Malaria and its various vertebrate hosts. In Malaria, Vol. 1, (ed. Kreier, J. P.), pp. 95-144. Academic Press, New York, NY, USA.
39. Gerdts, O. V. and Ortíz, E. B. (2004). Vacuna Colombiana contra anaplasmosis y babesiosis bovinas: la alternativa más eficaz y económica para el control de estos hemoparasitismos. http://www.cundinamarca.gov.co/cundinamarca/archivos/FILE-EVENTOSENTI/FILE-EVENTOSENT I11832.pdf.
40. Gruber, M. F. (2011). US FDA review and regulation of preventive vaccines for infectious disease indications: impact of the FDA Amendments Act 2007. Expert Review of Vaccines 10, 1011-1019. doi: 10.1586/erv.11.52.
41. Gubbels, M. J., Viseras, J., Habela, M. A. and Jongejan, F. (2000). Characterization of attenuated Theileria annulata vaccines from Spain and the Sudan. Tropical Veterinary Diseases 916, 521-532.
42. Hall, R., Ilhan, T., Kirvar, E., Wilkie, G., Preston, P. M., Darghouth, M., Somerville, R. and Adamson, R. (1999). Mechanism (s) of attenuation of Theileria annulata vaccine cell lines. Tropical Medicine and International Health 4, A78-A84.
43. Harp, J. A. and Goff, J. P. (1995). Protection ofcalves with avaccine against Cryptosporidium parvum. Journal of Parasitology 81, 54-57.
44. Hashemi-Fesharki, R. (1988). Control of Theileria annulata in Iran. Parasitology Today 4, 36-40. doi: 0169-4758(88)90062-2 [pii].
45. Hooshmand-Rad, P. (1985). The use of tissue culture attenuated live vaccine for Theileria hirci. Developments in Biological Standardization 62, 119-127.
46. Ishih, A., Kawakami, C., Todoroki, A., Hirai, H., Ohori, K. and Kobayashi, F. (2013). Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-gamma receptor-deficient mice following chloroquine treatment. Parasitology Research 112, 773-780. doi: 10.1007/s00436-012-3197-y.
47. Jeffers, T. K. (1975). Attenuation of Eimeria tenella through selection for precociousness. Journal of Parasitology 61, 1083-1090.
48. Kragh, J. V. (2010). Malaria fever therapy for general paralysis of the insane in Denmark. History of Psychiatry 21 (84 Pt 4), 471-486.
49. Latif, A. A. and Hove, T. (2011). History and critical review of Theileria parva (Boleni), the vaccine stock against Zimbabwean cattle theileriosis. Ticks and Tick Borne Diseases 2, 163-167. doi: 10.1016/j.ttbdis.2011.06.002.
50. Lawrence, J. A. (1997). Conventional vaccines for tick-borne haemopar-asitic diseases of sheep and goats. Parassitologia 39, 119-121.
51. Lecompte, E., Aplin, K., Denys, C., Catzeflis, F., Chades, M. and Chevret, P. (2008). Phylogeny and biogeography of African Murinae based on mitochondrial and nuclear gene sequences, witha new tribal classification of the subfamily. BMC Evolutionary Biology 8, 199. doi: 1471-2148-8-199 [pii] 10.1186/1471-2148-8-199.
52. Lehmann, C. and Lehmann, W. (2004). Giardia: infection and vaccination in an animal shelter. Tierarztliche Umschau 59, 337-340.
53. Lemesre, J. L., Holzmuller, P., Cavaleyra, M., Goncalves, R.B., Hottin, G. and Papierok, G. (2005). Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23, 2825-2840.
54. Lemesre, J. L., Holzmuller, P., Goncalves, R. B., Bourdoiseau, G., Hugnet, C., Cavaleyra, M. and Papierok, G. (2007). Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Vaccine 25, 4223-4234. doi: 10.1016/j.vaccine.2007.02.083.
55. Liebhart, D., Windisch, M. and Hess, M. (2010). Oral vaccination of 1-day-old turkeys with in vitro attenuated Histomonas meleagridis protects against histomonosis and has no negative effect on performance. Avian Pathology 39, 399-403. doi: 10.1080/03079457.2010.506906.
56. Liebhart, D., Sulejmanovic, T., Grafl, B., Tichy, A. and Hess, M. (2013). Vaccination against histomonosis prevents a drop in egg production in layers following challenge. Avian Pathology 42, 79-84. doi: 10.1080/03079457.2012.760841.
57. Long, P.L., Millard, B.J., Batty, A.F. and da Vison, C. (1982). Immunisation against coccidiosis in chickens: tests under simulated field conditions. Avian Pathology 11, 131-144. doi: 10.1080/03079458208436088.
58. Mangold, A. J., Vanzini, V. R., Echaide, I. E., de Echaide, S. T., Volpogni, M. M. and Guglielmone, A. A. (1996). Viability after thawing and dilution of simultaneously cryopreserved vaccinal Babesia bovis and Babesia bigemina strains cultured in vitro. Veterinary Parasitology 61, 345-348.
59. Marquardt, W. C., Demaree, R. S. and Grieve, R.B. (eds) (2000). Piroplasmea and piroplasmosis. In Parasitology and Vector Biology, pp. 211-224. Academic Press, San Diego, CA, USA.
60. Mateus-Pinilla, N. E., Dubey, J. P., Choromanski, L. and Weigel, R. M. (1999). A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. Journal of Parasitology 85, 855-860.
61. Mayrink, W., Mendonca-Mendes, A., de Paula, J. C., Siqueira, L. M., Marrocos Sde, R., Dias, E.S., de Andrade, H. M. and Machado-Coelho, G. L. (2013). Cluster randomised trial to evaluate the effectiveness of a vaccine against cutaneous leishmaniasis in the Caratinga microregion, south-east Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 107, 212-219. doi: 10.1093/trstmh/trt006.
62. McDonald, V. and Shirley, M. W. (2009). Past and future: vaccination against Eimeria. Parasitology 136, 1477-1489. doi: 10.1017/S0031182009006349.
63. McDougald, L. R. (1998). Intestinal protozoa important to poultry. Poultry Science 77, 1156-1158.
64. McDougald, L. R. and Jeffers, T.K. (1976). Eimeria tenella (Sporozoa, Coccidia): gametogony following a single asexual generation. Science 192, 258-259.
65. Miller, L.H., Good, M. F. and Milon, G. (1994). Malaria pathogenesis. Science 264, 1878-1883.
66. Nadim, A., Javadian, E., Tahvildar-Bidruni, G. and Ghorbani, M. (1983). Effectiveness of leishmanization in the control of cutaneous leishmaniasis. Bulletin de la Societe de pathologie exotique et de ses filiales 76, 377-383.
67. Nadim, A., Javadian, E. and Mohebali, M. (1997). The experience of leishmanization in the Islamic Republic of Iran. La Revue de Santé de la Méditerranée Orientale 3, 284-289.
68. NIFA (2009). Animal systems portfolio annual report, CSREES (now the National Institute of Food and Agriculture). United States Department of Agriculture. http://www.nifa.usda.gov/about/pdfs/par-as.pdf.
69. NIH (2012). Appropriations of the National Institutes of Health (United States). In The NIH Almanac. http://www.nih.gov/about/almanac/appropriations/index.htm.
70. Nogueira, F. S., Moreira, M. A., Borja-Cabrera, G. P., Santos, F. N., Menz, I., Parra, L. E., Xu, Z., Chu, H. J., Palatnik-de-Sousa, C. B. and Luvizotto, M. C. (2005). Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs. Vaccine 23, 4805-4810. doi: S0264-410X(05)00530-X [pii] 10.1016/j.vaccine.2005.05.011.
71. Ogutu, B. R., Apollo, O. J., McKinney, D., Okoth, W., Siangla, J., Dubovsky, F., Tucker, K., Waitumbi, J. N., Diggs, C., Wittes, J., Malkin, E., Leach, A., Soisson, L. A., Milman, J. B., Otieno, L., Holland, C. A., Polhemus, M., Remich, S. A., Ockenhouse, C. F., Cohen, J., Ballou, W. R., Martin, S. K., Angov, E., Stewart, V. A., Lyon, J.A., Heppner, D.G., Withers, M.R. and Group, M. S. P. M. V. W. (2009). Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya. PLoS ONE 4, e4708. doi: 10.1371/journal.pone.0004708.
72. Olotu, A., Fegan, G., Wambua, J., Nyangweso, G., Awuondo, K. O., Leach, A., Lievens, M., Leboulleux, D., Njuguna, P., Peshu, N., Marsh, K. and Bejon, P. (2013). Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure. New England Journal of Medicine 368, 1111-1120. doi: 10.1056/NEJMoa1207564.
73. Olson, M. E., Morck, D. W. and Ceri, H. (1997). Preliminary data on the efficacy of a Giardia vaccine in puppies. Canadian Veterinary Journal 38, 777-779.
74. Pakandl, M. (2005). Selection of a precocious line of the rabbit coccidium Eimeria flavescens Marotel and Guilhon (1941) and characterisation of its endogenous cycle. Parasitology Research 97, 150-155. doi: 10.1007/s00436-005-1411-x.
75. Palatnik-de-Sousa, C. B., Silva-Antunes, I., Morgado Ade, A., Menz, I., Palatnik, M. and Lavor, C. (2009). Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas. Vaccine 27, 3505-3512. doi: S0264-410X(09)00467-8 [pii] 10.1016/j.vaccine.2009.03.045.
76. Patel, E. H., Lubembe, D. M., Gachanja, J., Mwaura, S., Spooner, P. and Toye, P. (2011). Molecular characterization of live Theileria parva sporozoite vaccine stabilates reveals extensive genotypic diversity. Veterinary Parasitology 179, 62-68. doi: 10.1016/j.vetpar.2011.01.057.
77. Perlaza, B. L., Valencia, A. Z., Zapata, C., Castellanos, A., Sauzet, J. P., Blanc, C., Cohen, J., Arevalo-Herrera, M., Corradin, G., Herrera, S. and Druilhe, P. (2008). Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides. European Journal of Immunology 38, 2610-2615. doi: 10.1002/eji.200738055.
78. Pipano, E. (1997). Vaccines against hemoparasitic diseases in Israel with special reference to quality assurance. Tropical Animal Health and Production 29 (4 Suppl.), 86S-90S.
79. Radley, D. E., Brown, C. G. D., Cunningham, M. P., Kimber, C. D., Musisi, F. L., Payne, P. A., Purnell, R.E., Stagg, S. M. and Young, A. S. (1975). East coast fever: 3. Chemoprophylactic immunization of cattle using oxytetracycline and a combination of theilerial strains. Veterinary Parasitology 1, 51-60.
80. Reed, R. C., Louis-Wileman, V., Wells, R. L., Verheul, A. F., Hunter, R. L. and Lal, A. A. (1996). Re-investigation of the circumspor-ozoite protein-based induction of sterile immunity against Plasmodium berghei infection. Vaccine 14, 828-836.
81. Richards, W. H. G. (1966). Active immunization of chicks against Plasmodium gallinaceum by inactivated homologous sporozoites and erythrocytic parasites. Nature 212, 1492-1494.
82. Roestenberg, M., McCall, M., Hopman, J., Wiersma, J., Luty, A. J., van Gemert, G. J., van de Vegte-Bolmer, M., van Schaijk, B., Teelen, K., Arens, T., Spaarman, L., de Mast, Q., Roeffen, W., Snounou, G., Renia, L., van der Ven, A., Hermsen, C. C. and Sauerwein, R. (2009). Protection against a malaria challenge by sporozoite inoculation. New England Journal of Medicine 361, 468-477. doi: 10.1056/NEJMoa0805832.
83. Rogers, W. O., Weiss, W.R., Kumar, A., Aguiar, J. C., Tine, J. A., Gwadz, R., Harre, J. G., Gowda, K., Rathore, D., Kumar, S. and Hoffman, S. L. (2002). Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen. Infection and Immunity 70, 4329-4335.
84. Rutgers, T., Gordon, D., Gathoye, A. M., Hollingdale, M. R., Hockmeyer, W., Rosenberg, M. and De Wilde, M. (1988). Hepatitis B surface antigen as carrier matrix for the repetitive epitope of the circumsporozoite protein of Plasmodium falciparum. Bio/Technology 6, 1065-1070.
85. Sadun, E. H., Wellde, B.T. and Hickman, R. L. (1969). Resistance produced in owl monkeys (Aotus trivirgatus) by inoculation with irradiated Plasmodium falciparum. Military Medicine 134, 1165-1175.
86. Saraiva, E. M., de Figueiredo Barbosa, A., Santos, F. N., Borja-Cabrera, G. P., Nico, D., Souza, L. O., de Oliveira Mendes-Aguiar, C., de Souza, E. P., Fampa, P., Parra, L. E., Menz, I., Dias, J. G., Jr., de Oliveira, S.M. and Palatnik-de-Sousa, C. B. (2006). The FML-vaccine (Leishmune) against canine visceral leishman-iasis: a transmission blocking vaccine. Vaccine 24, 2423-2431. doi: S0264-410X(05)01217-X [pii] 10.1016/j.vaccine.2005.11.061.
87. Schetters, T.P. and Gravendyck, M. (2006). Regulations and procedures in parasite vaccine development. Parasitology 133 (Suppl.), S189-S195. doi: 10.1017/S0031182006001879.
88. Schetters, T. P., Kleuskens, J. A., Scholtes, N. C., Gorenflot, A., Moubri, K. and Vermeulen, A. N. (2001). Vaccination of dogs against heterologous Babesia canis infection using antigens from culture super-natants. Veterinary Parasitology 100, 75-86.
89. Schetters, T. P., Kleuskens, J. A., Scholtes, N.C., van de Crommert, J., Krijnen, E., Moubri, K., Gorenflot, A. and Vermeulen, A. N. (2006). Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants. Veterinary Parasitology 138, 140-146. doi: 10.1016/j. vetpar.2006.01.049.
90. Seder, R. A., Chang, L.J., Enama, M. E., Zephir, K. L., Sarwar, U.N., Gordon, I.J., Holman, L. A., James, E. R., Billingsley, P. F., Gunasekera, A., Richman, A., Chakravarty, S., Manoj, A., Velmurugan, S., Li, M., Ruben, A. J., Li, T., Eappen, A. G., Stafford, R.E., Plummer, S.H., Hendel, C. S., Novik, L., Costner, P. J., Mendoza, F. H., Saunders, J. G., Nason, M. C., Richardson, J. H., Murphy, J., Davidson, S. A., Richie, T. L., Sedegah, M., Sutamihardja, A., Fahle, G. A., Lyke, K. E., Laurens, M.B., Roederer, M., Tewari, K., Epstein, J.E., Sim, B. K., Ledgerwood, J. E., Graham, B.S., Hoffman, S. L. and the V. R. C. S. T. (2013). Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359-1365. doi: 10.1126/science.1241800.
91. Sergent, É. and Sergent, E. (1910). Sur l' immunité dans le paludisme des oiseaux. Conservation in vitro des sporozoites de Plasmodium relictum. Immunité relative obtenue par inoculation de ces sporozoites. Comptes Rendus de l'Académie des Sciences 151 (Séance Du August 1, 1910), 407-409.
92. Sharman, P. A., Smith, N. C., Wallach, M. G. and Katrib, M. (2010). Chasing the golden egg: vaccination against poultry coccidiosis. Parasite Immunology 32, 590-598. doi: 10.1111/j.1365-3024.2010.01209.x.
93. Shkap, V. and Pipano, E. (2000). Culture-derived parasites in vaccination of cattle against tick-borne diseases. Annals of the New York Academy of Sciences 916, 154-171.
94. Uilenberg, G. (1999). Immunization against diseases caused by Theileria parva: a review. Tropical Medicine and International Health 4, A12-A20.
95. USDA (2012). FY 2012 budget summary and annual performance plan of the United States Department of Agriculture. http://www.obpa.usda.gov/budsum/FY12budsum.pdf.
96. Vincke, I. H. and Lips, M. (1948). Un nouveau plasmodium d'un rongeur sauvage du Congo, Plasmodium berghei n. sp. [A new plasmodium of a wild rodent of Congo, Plasmodium berghei n. sp.]. Annales de la Société Belge de Médecine Tropicale 28, 97-104.
97. Wallach, M. G., Ashash, U., Michael, A. and Smith, N.C. (2008). Field application of a subunit vaccine against an enteric protozoan disease. PLoS ONE 3, e3948. doi: 10.1371/journal.pone.0003948.
98. Weston, J.F., Heuer, C. and Williamson, N.B. (2012). Efficacy of a Neospora caninum killed tachyzoite vaccine in preventing abortion and vertical transmission in dairy cattle. Preventive Veterinary Medicine 103, 136-144. doi: S0167-5877(11)00266-2 [pii] 10.1016/j. prevetmed.2011.08.010.
99. Wilkins, M. F., O'Connell, E. and Te Punga, W. A. (1988). Toxoplasmosis in sheep III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following experimental oral challenge. New Zealand Veterinary Journal 36, 86-89.
100. Williams, R. B. (2002). Fifty years of anticoccidial vaccines for poultry (1952-2002). Avian Diseases 46, 775-802.
101. Williams, R. B., Johnson, J. D. and Andrews, S. J. (2000). Anticoccidial vaccination of broiler chickens in various management programmes: relationship between oocyst accumulation in litter and the development of protective immunity. Veterinary Research Communications 24, 309-325.
102. Witonsky, S., Morrow, J.K., Leger, C., Dascanio, J., Buechner-Maxwell, V., Palmer, W., Kline, K. and Cook, A. (2004). Sarcocystis neurona-specific immunoglobulin G in the serum and cerebrospinal fluid of horses administered S. neurona vaccine. Journal of Veterinary Internal Medicine 18, 98-103.
103. Yin, H., Luo, J. and Lu, W. (2008). Control of tropical theileriosis with attenuated schizont vaccine in China. Vaccine 26 (Suppl. 6), G11-G13. doi: 10.1016/j.vaccine.2008.09.069.
104. Zhang, Z.H. (1997). A general review on the prevention and treatment of Theileria annulata in China. Veterinary Parasitology 70, 77-81.
105. Zintl, A., Mulcahy, G., Skerrett, H. E., Taylor, S. M. and Gray, J. S. (2003). Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance. Clinical Microbiology Reviews 16, 622-636.